Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Fatigue × Ultraviolet Therapy × Clear all

Phase

Phase NA 5 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Parasomnias 1 Fatigue 1 Depression 1 Anxiety Disorders 1

Interventions

Methylphenidate 3 Melatonin 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Ultraviolet Therapy 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sildenafil Citrate 1 Radiotherapy 1 Dexamethasone 1 Darbepoetin alfa 1 Consolidation Chemotherapy 1 Cognitive Behavioral Therapy 1 Chemoradiotherapy 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01193530 2019-03-26

The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Terminated

12 enrolled 3 charts

Anxiety Disorders, Depression, Fatigue, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡